Tobias Raum

MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors

Klaus Brischwein, Bernd Schlereth, Benjamin Guller et al. · Molecular Immunology · 2005 · 260 citations

Pharmacy, Medicinal Chemistry, Oncology +14

AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer

Michael J. Giffin, Keegan S. Cooke, Edward K. Lobenhofer et al. · Clinical Cancer Research · 2020 · 238 citations · Full text

Medicine, Oncology, Pharmacology +15

Comprehensive Analysis of NKG2D Ligand Expression and Release in Leukemia: Implications for NKG2D-Mediated NK Cell Responses

Julia Hilpert, Ludger Große‐Hovest, Frank Grünebach et al. · The Journal of Immunology · 2012 · 231 citations

Life Sciences, Immunology, Oncology +15

T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells

Ralf Lutterbuese, Tobias Raum, Roman Kischel et al. · Proceedings of the National Academy of Sciences · 2010 · 167 citations

Medicine, Oncology, Pharmacology +17

Regression of Human Prostate Cancer Xenografts in Mice by AMG 212/BAY2010112, a Novel PSMA/CD3-Bispecific BiTE Antibody Cross-Reactive with Non-Human Primate Antigens

Matthias Friedrich, Tobias Raum, Ralf Lutterbuese et al. · Molecular Cancer Therapeutics · 2012 · 146 citations

Life Sciences, Immunology, Oncology +17